These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1211 related items for PubMed ID: 16014534

  • 61. Anti-nucleosome antibodies in patients with systemic lupus erythematosus of recent onset. Potential utility as a diagnostic tool and disease activity marker.
    Simón JA, Cabiedes J, Ortiz E, Alcocer-Varela J, Sánchez-Guerrero J.
    Rheumatology (Oxford); 2004 Feb; 43(2):220-4. PubMed ID: 13130152
    [Abstract] [Full Text] [Related]

  • 62. [Studies on anti-DNA antibodies associated with renal involvement by enzyme-linked immunosorbent assay in patients with systemic lupus erythematosus].
    Taman J, Yabuki T, Furuyoshi S, Takata S, Kutsuki H, Miyawaki S.
    Ryumachi; 1996 Feb; 36(1):8-15. PubMed ID: 8711542
    [Abstract] [Full Text] [Related]

  • 63. Prevalence of antinucleosome antibodies by enzyme-linked immunosorbent assays in patients with systemic lupus erythematosus and other autoimmune systemic diseases.
    Půtová I, Dostal C, Becvar R.
    Ann N Y Acad Sci; 2007 Aug; 1109():275-86. PubMed ID: 17785316
    [Abstract] [Full Text] [Related]

  • 64. Association of alpha-actinin-binding anti-double-stranded DNA antibodies with lupus nephritis.
    Renaudineau Y, Croquefer S, Jousse S, Renaudineau E, Devauchelle V, Guéguen P, Hanrotel C, Gilburd B, Saraux A, Shoenfeld Y, Putterman C, Youinou P.
    Arthritis Rheum; 2006 Aug; 54(8):2523-32. PubMed ID: 16868973
    [Abstract] [Full Text] [Related]

  • 65. Autoantibodies against monomeric C-reactive protein in sera from patients with lupus nephritis are associated with disease activity and renal tubulointerstitial lesions.
    Tan Y, Yu F, Yang H, Chen M, Fang Q, Zhao MH.
    Hum Immunol; 2008 Dec; 69(12):840-4. PubMed ID: 18852001
    [Abstract] [Full Text] [Related]

  • 66. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential.
    Zhao Z, Weinstein E, Tuzova M, Davidson A, Mundel P, Marambio P, Putterman C.
    Arthritis Rheum; 2005 Feb; 52(2):522-30. PubMed ID: 15693007
    [Abstract] [Full Text] [Related]

  • 67. Complement degradation product C3d in urine: marker of lupus nephritis.
    Negi VS, Aggarwal A, Dayal R, Naik S, Misra R.
    J Rheumatol; 2000 Feb; 27(2):380-3. PubMed ID: 10685801
    [Abstract] [Full Text] [Related]

  • 68. Antibodies to ribosomal P proteins: a potential serologic marker for lupus membranous glomerulonephritis.
    do Nascimento AP, Viana Vdos S, Testagrossa Lde A, Leon EP, Borba EF, Barros RT, Bonfá E.
    Arthritis Rheum; 2006 May; 54(5):1568-72. PubMed ID: 16645990
    [Abstract] [Full Text] [Related]

  • 69. Diagnostic value of serum anti-C1q antibodies in patients with lupus nephritis: a meta-analysis.
    Yin Y, Wu X, Shan G, Zhang X.
    Lupus; 2012 Sep; 21(10):1088-97. PubMed ID: 22777943
    [Abstract] [Full Text] [Related]

  • 70. Repeated renal biopsy in proliferative lupus nephritis--predictive role of serum C1q and albuminuria.
    Gunnarsson I, Sundelin B, Heimbürger M, Forslid J, van Vollenhoven R, Lundberg I, Jacobson SH.
    J Rheumatol; 2002 Apr; 29(4):693-9. PubMed ID: 11950009
    [Abstract] [Full Text] [Related]

  • 71. Anti-nucleosome antibodies as a disease activity marker in patients with systemic lupus erythematosus.
    Suleiman S, Kamaliah D, Nadeem A, Naing NN, Che Maraina CH.
    Int J Rheum Dis; 2009 Jul; 12(2):100-6. PubMed ID: 20374326
    [Abstract] [Full Text] [Related]

  • 72. Anti-C1q autoantibodies specific against the globular domain of the C1qB-chain from patient with lupus nephritis inhibit C1q binding to IgG and CRP.
    Radanova M, Vasilev V, Deliyska B, Kishore U, Ikonomov V, Ivanova D.
    Immunobiology; 2012 Jul; 217(7):684-91. PubMed ID: 22209113
    [Abstract] [Full Text] [Related]

  • 73. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
    Horák P, Hermanová Z, Faltýnek L, Pospísil Z, Scudla V.
    Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876
    [Abstract] [Full Text] [Related]

  • 74. Significance of Anti-C1q Antibodies in Patients with Systemic Lupus Erythematosus as A Marker of Disease Activity and Lupus Nephritis.
    Soliman AF, Egailla SE, Abdel-Gawad ER, Mansour AI, ElKhouly TH, Mahgoub MY.
    Egypt J Immunol; 2016 Jan; 23(1):107-116. PubMed ID: 28502158
    [Abstract] [Full Text] [Related]

  • 75. High frequency of concurrent anti-C1q and anti-dsDNA but not anti-C3b antibodies in patients with Lupus Nephritis.
    Kianmehr N, Khoshmirsafa M, Shekarabi M, Falak R, Haghighi A, Masoodian M, Seif F, Omidi F, Shirani F, Dadfar N.
    J Immunoassay Immunochem; 2021 Jul 04; 42(4):406-423. PubMed ID: 33788670
    [Abstract] [Full Text] [Related]

  • 76. Clinical evaluation of a new quantitative enzyme-linked immunosorbent assay for detection of double-stranded DNA autoantibodies.
    Bardin N, Ragot C, Sanmarco M.
    Ann N Y Acad Sci; 2007 Aug 04; 1109():511-8. PubMed ID: 17785340
    [Abstract] [Full Text] [Related]

  • 77. Elevated production of serum B-cell-attracting chemokine-1 (BCA-1/CXCL13) is correlated with childhood-onset lupus disease activity, severity, and renal involvement.
    Ezzat M, El-Gammasy T, Shaheen K, Shokr E.
    Lupus; 2011 Jul 04; 20(8):845-54. PubMed ID: 21576203
    [Abstract] [Full Text] [Related]

  • 78. Active systemic lupus erythematosus is associated with depletion of the natural generic anti-idiotype (anti-F(ab')2) system.
    Williams RC, Malone CC, Huffman GR, Silvestris F, Croker BP, Ayoub EM, Massengill S.
    J Rheumatol; 1995 Jun 04; 22(6):1075-85. PubMed ID: 7674233
    [Abstract] [Full Text] [Related]

  • 79. Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus.
    Husebye ES, Sthoeger ZM, Dayan M, Zinger H, Elbirt D, Levite M, Mozes E.
    Ann Rheum Dis; 2005 Aug 04; 64(8):1210-3. PubMed ID: 15708887
    [Abstract] [Full Text] [Related]

  • 80. Anti-C1q autoantibodies from active lupus nephritis patients could inhibit the clearance of apoptotic cells and complement classical pathway activation mediated by C1q in vitro.
    Pang Y, Yang XW, Song Y, Yu F, Zhao MH.
    Immunobiology; 2014 Dec 04; 219(12):980-9. PubMed ID: 25092568
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 61.